$18.20
-0.29-1.57%
At close: -
$18.35
0.150.82%
After Hours: Jun 18, 7:12 PM EDT
Comments
Loading...
NewAmsterdam Pharma Co Stock Guidance | NASDAQ:NAMS | Benzinga
NewAmsterdam Pharma Co issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NewAmsterdam Pharma Co NV (NAMS) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for NewAmsterdam Pharma Co (NAMS)?
There have been no specific sales or earnings guidance reported for NewAmsterdam Pharma Co in recent months.
Browse guidance and forecast on all stocks.
